Menu
A study in the academic journal Cancer Medicine examined the relationship between the 340B program and prostate cancer care.

340B Program Had No Impact on Prostate Cancer Care, Study Suggests

Bella Czajkowski, National Correspondent 340B Report Views
Participation in the 340B program did not increase the number of vulnerable patients beginning targeted care for prostate cancer, a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

House E&C Health Leader Floats Major 340B Reform; Billions in Cuts to 340B Hospitals Under Consideration, Hospital Group Warns

BMS Allows Additional Contract Pharmacy Designation for Cancer Drug; Vertex Adds Cystic Fibrosis Drug to Restrictions

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live